Published in Cardiovascular Business Week, March 14th, 2006
Investigators working in the United States conducted a study "to determine the short- and long-term outcomes of patients treated operatively for Takayasu arteritis and the effect of disease activity on results."
C.E. Fields and colleagues at the Mayo Clinic explained, "Forty-two (17%) of the 251 patients enrolled in our Takayasu's arteritis registry between 1975 and 2002 required operation for symptomatic disease. Data were obtained from the registry, patient...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.